The University of Mississippi has launched the Resource Center for Cannabis and Cannabinoid Research (R3CR), a new initiative designed to support scientists across the country in navigating the regulatory and scientific hurdles surrounding marijuana research.
R3CR will operate within the university’s National Center for Natural Products Research (NCNPR), one of the nation’s leading marijuana research programs. Funded by the National Institutes of Health, the center is a collaboration between the University of Mississippi, Washington State University, and the United States Pharmacopeia.
“R3CR is a collaborative initiative designed to serve as a central hub for cannabis research resources and expertise”, states the center’s website. “By bringing together leading institutions and experts, we are working to break down barriers and advance the scientific understanding of cannabis.”
The center’s “core functions” include:
- Disseminating guidance and resources to empower cannabis researchers.
- Providing regulatory guidance to support compliant and effective research practices.
- Promoting quality and reproducibility in cannabis studies through standardized practices and resources.
The center will offer a suite of resources to researchers, including seed funding, educational webinars, national conferences, and an interactive website. These tools are designed to streamline regulatory compliance, strengthen research support, and help establish national standards for marijuana-based studies, with the ultimate goal of advancing the development of safe and effective cannabis-based therapies.
Key contributors include Donald Stanford, who will lead efforts to improve research quality; Mahmoud ElSohly, overseeing regulatory guidance; and Robert Welch, providing expertise on interpreting marijuana research policy. Mary Paine of Washington State University will head outreach and support, while Nandakumara Sarma of the U.S. Pharmacopeia will focus on research standards and best practices.
“People will realize significant changes in the landscape of cannabis research,” says Donald Stanford, assistant director of the Research Institute of Pharmaceutical Sciences, the institute that oversees the university’s natural products center. “Changes such as stronger and improved regulation compliance, development of more cannabis technologies, as well as the FDA receiving relevant safety data to make decisions on cannabinoids in foods and dietary supplements, can all eventually contribute to people’s health.
Mahmoud ElSohly, research professor in the natural products center and longtime director of the UM Marijuana Project, says “Because conducting cannabis studies involves a complexity of regulations of various federal and state agencies, both researchers and administrators must fully understand the requirements and must devise ways to comply in a practical manner. Our resource center will strive to provide guidance on matters such as this.”
